CN Stock MarketDetailed Quotes
301096 Hangzhou Bio-Sincerity Pharma-Tech
- 39.77
- +0.07+0.18%
Market Closed Dec 27 15:00 CST
4.34BMarket Cap20.48P/E (TTM)
40.07High39.32Low17.42KlotVolume39.73Open39.70Pre Close69.20MTurnover2.51%Turnover Ratio15.97P/E (Static)109.23MShares77.4852wk High1.57P/B2.76BFloat Cap33.5752wk Low47.64Limit Up69.43MShs Float118.30Historical High31.76Limit Down1.89%Amplitude33.57Historical Low0.30Dividend TTM39.73Avg Price8.63KlotAsk0.75%Div YieldTTM100Lot Size8.50KlotBid
Hangzhou Bio-Sincerity Pharma-Tech Key Stats
EPS
According to the latest financial report of Hangzhou Bio-Sincerity Pharma-Tech, the latest earnings per share (TTM) for the company is 1.31. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hangzhou Bio-Sincerity Pharma-Tech's latest financial report to see how much their book value per share (BVPS) is currently at 25.36.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hangzhou Bio-Sincerity Pharma-Tech shows that the company's current ratio is 1.94, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the quick ratio is 1.75, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hangzhou Bio-Sincerity Pharma-Tech? The latest ROE figure is 5.19%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the total asset return on investment (ROA) is 3.81%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hangzhou Bio-Sincerity Pharma-Tech's latest financial report to see how their gross margin is doing - currently at 61.17%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hangzhou Bio-Sincerity Pharma-Tech, the net profit margin is 19.62%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
